Position in SRRK
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$164,218,586
+$41,090,555 QoQ
Shares Held
3,340,492
+19.5% QoQ
Ownership
2.79%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 85.85702345642498.ToString("F0")%
Shared 0.ToString("F0")%
None 14.142976543575017.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JENNISON ASSOCIATES LLC holds $3,287,290,858 across 47 Biotechnology names. SRRK ranks #3 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,740,059 | $1,223,545,945 | |
| 2 | ARGX |
Argenx SE
|
237,468 | $173,411,007 | |
| 3 | SRRK |
Scholar Rock Holding Corp
This page
|
3,340,492 | $164,218,586 | |
| 4 | TARS |
Tarsus Pharmaceuticals, Inc.
|
1,712,124 | $120,105,497 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
4,980,770 | $117,346,940 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
1,072,011 | $112,989,959 | |
| 7 | INSM |
INSMED Inc
|
604,694 | $98,879,562 | |
| 8 | PCVX |
Vaxcyte, Inc.
|
1,698,011 | $98,671,418 |
All Filings in SRRK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $164,218,586 | 3,340,492 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $123,128,031 | 2,795,188 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $59,826,506 | 1,606,512 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $12,961,807 | 365,946 | Shares | Defined | 2025-08-01 | |
| 2024-06-30 | $1,172,664 | 140,776 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $2,459,014 | 138,458 | Shares | Defined | 2024-05-02 | |
| 2023-12-31 | $2,576,521 | 137,049 | Shares | Defined | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||